Biomea Fusion, Inc. Common Stock
Here’s whether Biomea Fusion, Inc. Common Stock (BMEA) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+10.20% over 10 days); strong 1-year return of +39.0%; 3-month momentum positive (+56.7%); rising volume confirms the move (1.35x 30d avg). Concerns: RSI 82 — overbought, elevated pullback risk. Currently 28.2% off its 52-week high. Score: +6/7.
BMEA is in a confirmed uptrend, trading above both its 50-day ($1.43) and 200-day ($1.54) moving averages. With an RSI of 82.0, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +39.0% compares to +35.1% for SPY (beat the market by 3.9%). The current 28.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.